Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial-Reference-Cited by-同舟云学术

Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial

Published:1993-12 Issue:7 Volume:22 Page:1763-1772
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Terrin Michael L,Williams David O,Kleiman Neal S,Willerson MD,Mueller Hiltrud S,Desvigne-nickens Patrice,Forman Sandra A,Knatterud Genell L,Braunwald Eugune

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction;N Engl J Med,1989

2. One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II trial;Williams;Circulation,1992

3. Hemorrhagic events during therapy with recombinant tissu-type plasminogen activator, heparin, and aspirin for acute myocardial infarction, Results of the Thrombolysis in Myocardial Infraction (TIMI) Phase II trial;Bovill;Ann Intern Med,1991

4. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin;Canner;J Am Coll Cardiol,1988

5. Mortality rates after 10.5 years for paticipants in the Multiple Risk Factor Intervention trial, Findings related to a priori hypotheses of the trial;JAMA,1990

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD;Journal of the American Society of Nephrology;2021-10-29

2. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention;Heart;2012-05-09

3. Risk Stratification after Acute ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction;Clinical Nuclear Cardiology;2010

4. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial;American Heart Journal;2009-04

5. Autoptic study in patients with ST-segment elevation myocardial infarction treated with fibrinolysis, angioplasty or conventional therapy aimed at breaking the heart as a cause of exitus;G ITAL CARDIOL;2008